Jules Bordet

Type: Person
Name: Jules Bordet
First reported Aug 29 2014 - Updated Aug 29 2014 - 1 reports

ONLINE FIRST: HERA Trastuzumab Trial Shows Lower Risk of Cardiac Problems in HER2-Positive Breast Cancer Patients

BY KURT SAMSONWhen administered for up to two years, the monoclonal antibody trastuzumab did not increase heart-related problems in otherwise healthy women with early-stage human epidermal growth factor receptor 2 (HER2)-positive breast cancer after chemotherapy ... [Published Oncology Times - Aug 29 2014]
First reported Aug 20 2014 - Updated Aug 20 2014 - 1 reports

Applications open for ESMO Palliative Care Fellowships 2015-16

ESMO – the European Society for Medical Oncology – supports oncology professionals in providing cancer patients with the most effective treatment and care. Part of this work involves a fellowship programme, which provides young oncologists time dedicated ... [Published EHospice - Aug 20 2014]

More Content

All (5) | News (5) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
ONLINE FIRST: HERA Trastuzumab Trial Shows Lowe... [Published Oncology Times - Aug 29 2014]
Applications open for ESMO Palliative Care Fell... [Published EHospice - Aug 20 2014]
Hormone Refractory Breast Cancer Global Clinica... [Published BioPortfolio - Mar 21 2014]
Volpara Solutions Launches Two Quantitative Bre... [Published PRWeb - Mar 07 2014]
arGEN-X begins phase Ib expansion cohorts with ... [Published PharmaBiz - Jan 14 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.